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Abstract
Background: Effective provider-parent communication can improve childhood vaccination uptake and strengthen
immunisation services in low- and middle-income countries (LMICs). Building capacity to improve communication
strategies has been neglected. Rigorous research exists but is not readily found or applicable to LMICs, making it
difficult for policy makers to use it to inform vaccination policies and practice.
The aim of this project is to build research knowledge and capacity to use evidence-based strategies for improving
communication about childhood vaccinations with parents and communities in LMICs.
Methods and design: This project is a mixed methods study with six sub-studies. In sub-study one, we will
develop a systematic map of provider-parent communication interventions for childhood vaccinations by screening
and extracting data from relevant literature. This map will inform sub-study two, in which we will develop a
taxonomy of interventions to improve provider-parent communication around childhood vaccination. In sub-study
three, the taxonomy will be populated with trial citations to create an evidence map, which will also identify how
evidence is linked to communication barriers regarding vaccination.
In the project’s fourth sub-study, we will present the interventions map, taxonomy, and evidence map to
international stakeholders to identify high-priority topics for systematic reviews of interventions to improve
parent-provider communication for childhood vaccination. We will produce systematic reviews of the effects of
high-priority interventions in the fifth sub-study. In the sixth and final sub-study of the project, evidence from
the systematic reviews will be translated into accessible formats and messages for dissemination to LMICs.
Discussion: This project combines evidence mapping, conceptual and taxonomy development, priority setting,
systematic reviews, and knowledge transfer. It will build and share concepts, terms, evidence, and resources to aid
the development of communication strategies for effective vaccination programmes in LMICs.
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Vaccination is one of the most cost-effective public
health interventions to significantly reduce childhood
mortality and morbidity [1]. It has widespread public
health benefits and is viewed as a public good [2,3].
Strategies that increase vaccination uptake involve ‘sup-
ply-side’ components, such as availability of effective
vaccines, adequate health systems to support their deliv-
ery and health personnel to administer the vaccines [4];
and ‘demand-side’ components, such as household and
individual determinants (e.g., building the knowledge
and agency of individuals to utilise such programmes to
their benefit). Particularly relevant examples of demand-
side components are those addressing barriers to vacci-
nation associated with parental knowledge, understand-
ing, attitudes, beliefs, and behaviours [5-10], such as
strategies to remind parents to get their children vacci-
nated [11]. In research and policy, more attention has
focussed on supply-side approaches to the neglect of the
demand-side [7,12].
Despite increases in vaccination rates in many coun-
tries in the last decade, great inequities exist between
and within countries. Besides this, more than 24 million
children still do not have access to basic immunisation
services [7,13]. Increasing vaccination rates among dis-
advantaged sectors of a community remains a challenge,
for practical, social, and socio-political reasons [14-16].
The project
The Communicate to Vaccinate (COMMVAC) project
is a part of the Global Health and Vaccination Research
(GLOBVAC) programme, funded by the Research Coun-
cil of Norway. The main aim of the COMMVAC project
is to build research knowledge and capacity to use evi-
dence-based strategies for improving communication
about childhood vaccinations with parents and commu-
nities in low- and middle-income countries (LMICs).
Communication for vaccination
Effective communication has the potential to improve
childhood vaccination uptake, address partial immunisa-
tion, further strengthen routine immunisation services,
and increase the use of new and underused vaccines in
LMICs.
A communication intervention can be defined as a
purposeful, structured, repeatable, and adaptable strat-
egy [17] to inform and influence individuals, commu-
nities, or health services and systems. Communication
interventions may affect consumers’ participation in
health initiatives, disease prevention and promotion pro-
grammes, policy making, service management, and
research. Such interventions may be implemented
through diverse forms of media. For the sake of brevity,
we use the phrase ‘communication interventions’ to
refer to a wide variety of interventions to inform, edu-
cate, communicate with, involve, and support people in
the management of their health [18].
A range of such interventions may be utilised in vac-
cine programmes. These may operate at individual,
community, or societal levels, and target people in their
role as parents or community members. In the context
of childhood vaccination policy and programmes, com-
munication strategies may encompass a variety of inter-
ventions, such as: public information campaigns [19];
education strategies that are tailored to local cultures
[20] or accessible to those with low health literacy [21];
addressing missed vaccinations with reminder systems
[22]; giving parents the information to assess and man-
age side effects [23]; and involving community members
in planning and evaluating programmes [24].
Finding rigorous evidence of the effects of
communication interventions
Evidence is available from individual studies on the
effects of a range of communication interventions, but
there are few systematic reviews that have critically
appraised and summarised existing research. Further-
more, LMIC programme managers and policy makers
who try to seek guidance for developing new approaches
to addressing barriers to vaccination uptake may find
that the available information does not appear to be
applicable to LMICs because these studies were con-
ducted in very different social contexts and health sys-
tems settings. Systematic identification and review of the
range of interventions used in practice is therefore
needed urgently. This should describe the scope of
interventions available and provide information on how
they operate, how best to deliver them, and their effects
across different settings. It should also examine the
applicability of these findings across different contexts.
This project will draw from and build upon existing
specialised knowledge resources for describing, categor-
ising, and evaluating interventions to improve communi-
cation with people about their health and healthcare
[17,25]. The terminology has been developed within the
health communication domain to create a shared lan-
guage so that knowledge resources– including concepts,
practices, interventions, and evidence–can be universally
understood and used to promote improvements in
health outcomes.
Methods and design
The COMMVAC project is an international collabora-
tion, with project partners in Norway, Australia, South
Africa, France, and Switzerland. The project’sp r i n c i p a l
investigator is located in Oslo, Norway (SL).
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Each sub-study will build upon the outputs of the pre-
vious sub-studies (see Figure 1).
All of the data used in this project will be obtained
from published studies or from public deliberative
forums and therefore do not raise significant ethical
issues. Ethical approval will be sought in Norway for the
deliberative forums because this will involve document-
ing the discussions of key stakeholders and summarising
these for distribution in the public domain.
ProjectStages Outputs
Adetailedmap,scopingfeaturesof
communicationinterventionsfor
vaccination(e.g.,purpose,format,and
deliverymode)andlinkedtoidentified
communicationbarriers
Aformaltaxonomyofcommunication
forvaccinationinterventionsthatcan
beusedasatoolbyhealthsect
stakeholders
or
Areportonlevelsofavailableevidence
toinformthedeliberativeforum
describedinsubͲstudy4below
Identificationofrankedprioritiesfor
systematicreviewsofinterventionsto
improvecommunicationfor
vaccination;identificationof
additionalbarrierstovaccination;and
agreementonhowinformationonles
rigorousevaluationsshouldbe
dissemina
s
tedtothefield
Twotothreesystematicreviewsofhigh
prioritytopicswithhighrelevanceto
LMICs
SubͲstudy1:Developinga
systematicmapof
interventionsfor
communicatingwithparents
aboutchildhoodvaccination
Highlyaccessibleevidencesummaries
distributedtopotentialusersvia
multipleroutestoinformdecisionson
theimplementationof‘communicate
tovaccinate’interventions
Deliberativeforums
heldinpersonand
onlinetoprovide
feedbackontaxonomy
andidentifyhigh
prioritytopicsfor
systematicreviews
SubͲstudy2:Developinga
taxonomyofinterventions
toimprovecommunication
betweenprovidersand
parentsaroundchildhood
vaccination
SubͲstudy3:Populatingthe
taxonomywithevidenceof
theeffectsoftheidentified
interventions
SubͲstudy4:Identifyinghigh
prioritytopicsforsystematic
reviewsoroverviewsof
interventionstoimprove
communicationaround
childhoodvaccination
SubͲstudy5:Systematic
reviewsoftheevidencefor
theeffectivenessofhigh
priorityinterventionsto
improveproviderͲparent
communicationaround
childhoodvaccination
SubͲstudy6:Developing
‘communicatetovaccinate’
evidencesummaries
Figure 1 Flow chart of the stages of the COMMVAC project.
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on the direction and implementation of the project;
make suggestions regarding where to seek specialist
advice; provide input on the interpretation of findings
and the development of recommendations; and advise
on, and promote dissemination of the project findings.
Sub-study one: Developing a systematic map of
interventions for communicating with parents
about childhood vaccination
Rationale
Globally, a wide range of interventions that involve
communication to improve vaccination has been devel-
oped and evaluated, but this disparate evidence is not
available in an organised manner that can inform deci-
sion making. It is also not clear to what extent available
interventions address barriers to vaccination identified
by or relevant to stakeholders, including consumers and
programme managers. Systematically mapping the evi-
dence provides an explicit means to identify the scope
of available interventions and the quality of evidence on
their effectiveness, assess where evidence ‘gaps’ exist,
and determine options for future programme planning
[26].
Methods
Systematic maps draw on the same rigorous and trans-
parent methods used for systematic reviews of effects,
but focus on documenting and describing the range of
interventions available rather than their effects [27,28].
We will search multiple databases for literature describ-
ing or evaluating communication interventions related
to childhood vaccination, selecting on key criteria of
communication intervention (defined comprehensively
as per the Cochrane Consumers & Communication
Review Group scope [25]) and childhood vaccination.
The databases of primary focus will be the Cochrane
Central Register of Controlled Trials (CENTRAL) and
MEDLINE. For each communication intervention identi-
fied, we will extract descriptive information on the aim
of the intervention, population(s) targeted, intervention
content and tools used to deliver the intervention, eva-
luation design (where applicable), and outcomes
assessed [29]. We will also link these interventions to
known barriers to improved vaccination uptake [8,30]
and examine relationships between intervention types
and delivery context.
The construction of the interventions map will entail
extracting and mapping the following data from all
included studies, with particular attention paid to cap-
turing information about interventions in a systematic
and structured way [29,31]:
1. Communication barriers identified (if any)
2. Population features: population group; setting of
vaccination services (i.e., country and region, urban, or
rural); vaccination delivery strategy, details of vaccine
dose and coverage; and age of infants or children
3. Communication intervention features: intervention
purpose; direction of communication [32]; parties
involved; content of communication; format and delivery
mode; deliverer (i.e., service type or personnel); training
required; setting; frequency or timing of communication;
and cost
4. Outcome features: main outcomes measured (where
applicable); and side effects.
Rigorous effects studies (i.e., controlled trials) will be
evaluated on additional characteristics using existing
checklists. These data will allow us to describe where, in
relation to the interventions map, robust evidence of
effectiveness is available, informing later project sub-
studies.
Output
The output of sub-study one is a detailed map, scoping
features of communication interventions for vaccination
(e.g., purpose, format, and delivery mode) and linked to
identified communication barriers.
Sub-study two: Developing a taxonomy of
interventions to improve communication between
providers and parents around childhood
vaccination
Rationale
Despite the importance of communication to vaccine
delivery and uptake, we are not aware of any compre-
hensive approach to organising, and therefore under-
standing, communication interventions related to
childhood vaccination. Developing a classification sys-
tem, organised into categories based on conceptual or
practical similarities (a taxonomy), of communication
interventions will help to: understand the relationships
between different types of interventions in the field;
facilitate conceptual mapping of these interventions;
clarify the key purposes and features of interventions,
thereby assisting with implementation and evaluation;
and identify areas where evidence is strong and where
there are gaps. While the intervention map (sub-study
one) will provide a descriptive overview of the ‘land-
scape’ of communication for vaccination, the taxonomy
will provide a relatively discrete set of types of interven-
tions and illustrate relationships between differently
described interventions.
Methods
We will build on taxonomies already developed, includ-
ing: a comprehensive listing of all interventions for
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communication [25]; and a taxonomy of interventions
directed to consumers for evidence-based prescribing
[ 3 3 ] .W ew i l ld e v e l o pt h ev a c cination communication
taxonomy by using known barriers to improving com-
munication for vaccination as well as the studies identi-
fied in sub-study one. We will also refine the taxonomy
through discussions with communication and vaccina-
tion experts and potential users from a range of settings.
Output
The output of sub-study two is a formal taxonomy of
communication for vaccination interventions that can
be used as a tool by health sector stakeholders to iden-
tify gaps and research priorities, build future evidence,
and clarify purposes for communication.
Sub-study three: Populating the taxonomy with
evidence of the effects of the identified
interventions
Rationale
A key step towards building a knowledge base is being
able to identify, in relation to the categories of commu-
nication interventions identified in the taxonomy: where
high-quality evidence of effectiveness exists; where there
are potentially useful interventions but little high-quality
evidence of their effects; and where interventions are
being mentioned but have not been evaluated.
Methods
The literature identified in sub-study one will be used to
populate the taxonomy with citations of trials, or less
rigorous evaluations where trials do not exist. We will
then examine in detail each of the taxonomy categories
to ascertain where rigorous effectiveness evaluations
exist and where there are major knowledge gaps regard-
ing effects. We will first consider the global evidence
and then the evidence available from LMICs.
Output
The output of sub-study three is a report on levels of
available evidence to inform the deliberative forums
described in sub-study four below.
Sub-study four: Identifying high-priority topics
for systematic reviews or overviews of the effect
of interventions to improve communication
around childhood vaccination
Rationale
Resources to conduct high-quality systematic reviews of
effects are limited. The involvement of key stakeholders
in setting priorities for systematic reviews of effect will
help to ensure the relevance of review outputs for future
service provision. Stakeholders include government and
non-government agencies, bilateral and multilateral
agencies, global health initiatives, and programme per-
sonnel, as well as consumer groups.
Methods
We will hold a series of deliberative forums for key sta-
keholders [34,35]. The purposes of the forums will be to
discuss the outputs of the previous stages; comment on
the rigour of the available evaluations of interventions
and contribute practice knowledge that is missing from
the research; ensure that issues of setting, culture,
resources, and equity have been considered adequately;
and discuss and agree on priorities for systematic
reviews and further evaluations of the effect of
interventions.
Output
Outputs of sub-study four include: identification of
ranked priorities for systematic reviews of interventions
to improve communication for vaccination; identifica-
tion of additional barriers to vaccination; and agreement
on how information on less rigorous evaluations should
be disseminated to the field. Feedback on the taxonomy
will be incorporated into updated versions of the out-
puts of sub-studies two and three through an iterative
process (see Figure 1).
Sub-study five: Systematic reviews of the effect of
high-priority interventions to improve provider-
parent communication around childhood
vaccination
Rationale
Systematic reviews of effect will contribute to bridging
evidence gaps on communication interventions for pro-
moting vaccination uptake.
Methods
The reviews will focus on two to three high-priority
review topics identified in sub-study four, and will be
conducted according to the methods recommended by
the Cochrane Collaboration [36,37].
Outputs
The outputs of sub-study five are two to three systema-
tic reviews of the effect of interventions with high rele-
vance to LMICs.
Sub-study six: Developing ‘communicate to
vaccinate’ evidence summaries
Rationale
Policy makers and managers wanting to make well-
informed decisions about how best to improve com-
munication for vaccination need reliable, accessible,
and up-to-date evidence. However, systematic reviews
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Furthermore, it is often difficult for review users to
know how confident they should be in the quality of
the evidence as well as in its implications and local
applicability.
Methods
Drawing on an approach that the authors have piloted
extensively [38-40], we will produce ‘evidence bulletins’
summarising evidence from high-priority systematic
reviews identified or produced in this project. Each bul-
letin will include: key findings; an assessment of the
confidence that can be placed in these findings [41]; and
a discussion of key implementation issues, such as
applicability in LMICs, equity impacts and monitoring
needs. The bulletins will also summarise lessons emer-
g i n gf r o mt h ep r o j e c t .T h e yw i l lb ed i s s e m i n a t e d
through networks such as the ‘Vaccines for Africa’
initiative and the International Union for Health Promo-
tion and Education (IUHPE).
Outputs
The outputs for sub-study six are highly accessible evi-
dence summaries distributed to potential users via mul-
tiple routes to inform decisions on the implementation
of ‘communicate to vaccinate’ interventions.
Discussion
There are significant knowledge gaps regarding how
more effective communication between parents and
healthcare providers can be used to improve childhood
vaccination rates in LMICs. However, conducting new
primary research in the absence of a comprehensive
synthesis of existing knowledge is wasteful. We propose
to synthesise and build on what is already known and
evaluated, in a research design that is informed by the
priorities of key stakeholders, including consumers. The
COMMVAC project will not only provide useful, applic-
able evidence of the effectiveness of relevant interven-
tions through systematic reviews, it will also produce a
valuable map of the existing evidence landscape. This
map can be used to identify gaps and prioritise future
primary and secondary research.
Efforts to improve vaccination coverage in LMICs are
central to meeting the Millennium Development Goal
(MDG) of reducing child mortality [42]. While many of
the vaccines needed to save children’s lives already exist,
improvements in coverage will depend in part on more
effective communication between healthcare providers
and the parents and caregivers of children. The COMM-
VAC project will add substantially to our understanding
of ‘communication for vaccination’–a neglected area of
study. Working with key immunisation stakeholders,
this project will produce high-quality evidence on
effective communication strategies for vaccination in
LMICs and will package this evidence in formats that
are accessible to programme managers. Through these
outputs, the project has the potential to improve child
health and contribute to meeting the MDGs. More
effective communication may also have wider impacts
through improving care quality for other health services
for children and adults.
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